Standardized Brain Tumor Imaging Protocol for Clinical Trials

Affiliations

¹ Department of Medical and Scientific Affairs ICON Clinical Research Warrington, Pennsylvania.
² David Geffen School of Medicine University of California, Los Angeles Los Angeles, California.
³ Brown Alpert Medical School Brown University Providence, Rhode Island.
⁴ Department of Radiology Duke University School of Medicine Durham, North Carolina.
⁵ Department of Radiology UCLA Medical Center Los Angeles, California.
⁶ Center for Cancer Research National Institutes of Health Bethesda, Maryland.

Comment

G V Goldmacher et al. AJNR Am J Neuroradiol. 2015 Oct.

. 2015 Oct;36(10):E65-6.

doi: 10.3174/ajnr.A4544. Epub 2015 Sep 10.

¹ Department of Medical and Scientific Affairs ICON Clinical Research Warrington, Pennsylvania.
² David Geffen School of Medicine University of California, Los Angeles Los Angeles, California.
³ Brown Alpert Medical School Brown University Providence, Rhode Island.
⁴ Department of Radiology Duke University School of Medicine Durham, North Carolina.
⁵ Department of Radiology UCLA Medical Center Los Angeles, California.
⁶ Center for Cancer Research National Institutes of Health Bethesda, Maryland.

No abstract available

Comment on

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.
Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR; Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. Ellingson BM, et al. Neuro Oncol. 2015 Sep;17(9):1188-98. doi: 10.1093/neuonc/nov095. Epub 2015 Aug 5. Neuro Oncol. 2015. PMID: 26250565 Free PMC article. Review.

1. Ellingson B, Bendszus M, Boxerman J, et al. . Consensus recommendations for a standardized Brain Tumor Imaging Protocol (BTIP) in clinical trials. Neuro Oncol 2015;17:1188–98 10.1093/neuonc/nov095 - DOI - PMC - PubMed
1. European Organisation for Research and Treatment of Cancer. Bevacizumab and lomustine for recurrent GBM. http://clinicaltrials.gov/show/NCT01290939. Accessed July 30, 2015.